The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats
Authors:
- 30 June 2011
- journal article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 36 (4) , 205-211
Abstract
The aim of this study was to explore potential herb–drug interaction between danshensu or ursolic acid and rosuvastatin. Compared to the control group given rosuvastatin alone, the concurrent use of danshensu (46 mg/kg) or ursolic acid (80 mg/kg) prior to the oral administration of rosuvastatin (100 mg/kg) increased the systemic exposure of rosuvastatin more than twofold. The plasma clearance of rosuvastatin was reduced to more than 57% in the presence of danshensu or ursolic acid. Rosuvastatin is minimally metabolized in the CYP2C9 isoenzyme pathway and to an even lesser extent in the CYP2C19 isoenzyme pathway. Rosuvastatin is a substrate of drug transporters such as human OATP1B1, OATP 1B3, OATP 1A2, BCRP and NTCP. Therefore, the present results suggested that the potential drug interaction between danshensu or ursolic acid and rosuvastatin may be mediated by one or more transporters (OATP1B1, OATP 1B3, OATP 1A2, BCRP and NTCP) and/or CYPs.Keywords
This publication has 31 references indexed in Scilit:
- Development of a Cell-Based High-Throughput Assay to Screen for Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3Current Chemical Genomics, 2010
- OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteersJournal of Clinical Pharmacy and Therapeutics, 2010
- Involvement of Multiple Transporters in the Hepatobiliary Transport of RosuvastatinDrug Metabolism and Disposition, 2008
- Rosuvastatin: efficacy, safety and clinical effectivenessExpert Opinion on Pharmacotherapy, 2008
- Danshen: A versatile Chinese herbal drug for the treatment of coronary heart diseaseInternational Journal of Cardiology, 2006
- EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-BDrug Metabolism and Disposition, 2006
- Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunctionLife Sciences, 2004
- Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatinXenobiotica, 2003
- A Review of the Pharmacologic and Pharmacokinetic Aspects of RosuvastatinThe Journal of Clinical Pharmacology, 2002
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.The American Journal of Cardiology, 2001